应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ATRA Atara Biotherapeutics
休市中 05-31 16:00:00 EDT
0.5609
-0.0073
-1.28%
盘后
0.5500
-0.0109
-1.94%
19:59 EDT
最高
0.5887
最低
0.5500
成交量
107.92万
今开
0.5681
昨收
0.5682
日振幅
6.81%
总市值
6,754万
流通市值
5,194万
总股本
1.20亿
成交额
60.73万
换手率
1.17%
流通股本
9,260万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Atara Biotherapeutics, Inc.盘中异动 大幅上涨5.07%报0.588美元
自选股智能写手 · 05-30 21:54
Atara Biotherapeutics, Inc.盘中异动 大幅上涨5.07%报0.588美元
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.04%
自选股智能写手 · 05-29 22:39
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.04%
Atara Biotherapeutics, Inc.盘中异动 急速上涨5.10%
自选股智能写手 · 05-28
Atara Biotherapeutics, Inc.盘中异动 急速上涨5.10%
Adiumentum Capital Fund I LP 表示收购的 Atara Biotherapeutics 普通股 Belief 股票的实益所有权被低估
智通财经 · 05-23
Adiumentum Capital Fund I LP 表示收购的 Atara Biotherapeutics 普通股 Belief 股票的实益所有权被低估
Atara Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.15%报0.729美元
自选股智能写手 · 05-23
Atara Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.15%报0.729美元
Atara Biotherapeutics, Inc.盘中异动 早盘急速下跌5.00%
自选股智能写手 · 05-13
Atara Biotherapeutics, Inc.盘中异动 早盘急速下跌5.00%
Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.59%
自选股智能写手 · 05-10
Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.59%
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.21%
自选股智能写手 · 05-07
Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.21%
Atara Biotherapeutics, Inc.盘中异动 股价大跌5.63%
自选股智能写手 · 05-07
Atara Biotherapeutics, Inc.盘中异动 股价大跌5.63%
加载更多
公司概况
公司名称:
Atara Biotherapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。公司是一个临床阶段的生物制药公司,致力于开发对肌肉萎缩情况和肿瘤学严重的未满足的医疗需求的新疗法。公司的候选产品是针对肌肉生长抑制素和激活素生物制剂,是TGF-β蛋白超家族的成员,它在肌肉和其他许多身体组织的生长和维持中发挥作用。公司的主导候选产品,PINTA745,是在终末期肾病患者的第2阶段临床试验PEW。该公司第二候选产品为STM434,以及该公司预计将在2014年下半年进入STM434的第1阶段临床研究卵巢癌等实体瘤。
发行价格:
--
{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":0.5609,"timestamp":1717185600000,"preClose":0.5682,"halted":0,"volume":1079181,"hourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.5609,"latestTime":"19:59 EDT","volume":20164,"amount":11767.4355,"timestamp":1717199986730},"delay":0,"floatShares":92599395,"shares":120416138,"eps":-2.030159,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0073,"latestTime":"05-31 16:00:00 EDT","open":0.5681,"high":0.5887,"low":0.55,"amount":607279.81877766,"amplitude":0.06811,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.030159,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"listingDate":1413432000000,"adjPreClose":0.5682,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.5721,"preClose":0.5682,"latestTime":"09:16 EDT","volume":841,"amount":484.7251516,"timestamp":1717161418266},"postHourTrading":{"tag":"盘后","latestPrice":0.55,"preClose":0.5609,"latestTime":"19:59 EDT","volume":20164,"amount":11767.4355,"timestamp":1717199986730},"volumeRatio":1.1421643430513615},"requestUrl":"/m/hq/s/ATRA/","defaultTab":"news","newsList":[{"id":"2439415640","title":"Atara Biotherapeutics, Inc.盘中异动 大幅上涨5.07%报0.588美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439415640","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439415640?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:54","pubTimestamp":1717077242,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时54分,Atara Biotherapeutics, Inc.股票出现异动,股价快速拉升5.07%。截至发稿,该股报0.588美元/股,成交量6.9193万股,换手率0.06%,振幅3.52%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃,换手率分别为66.71%、31.21%、28.31%,振幅较大的相关个股有Kintara Therapeutics, Inc.、Onconetix, Inc.、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为34.78%、23.74%、20.65%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530215402941eb352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530215402941eb352&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2439575004","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439575004","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439575004?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:39","pubTimestamp":1716993578,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时39分,Atara Biotherapeutics, Inc.股票出现异动,股价大幅下跌5.04%。截至发稿,该股报0.581美元/股,成交量13.5561万股,换手率0.11%,振幅5.95%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.98%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、Aeon Biopharma, Inc.涨幅较大,Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃,换手率分别为315.05%、93.70%、26.61%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、冠科美博,振幅分别为97.00%、50.08%、44.82%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529223938af8aeff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529223938af8aeff1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2438372169","title":"Atara Biotherapeutics, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438372169","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2438372169?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:31","pubTimestamp":1716903098,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时31分,Atara Biotherapeutics, Inc.股票出现异动,股价快速上涨5.10%。截至发稿,该股报0.656美元/股,成交量4.5996万股,换手率0.04%,振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.82%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大,Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃,换手率分别为18.24%、7.41%、7.07%,振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Sensei Biotherapeutics, Inc.,振幅分别为14.67%、13.15%、10.20%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282131389ef99d45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282131389ef99d45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437240336","title":"Adiumentum Capital Fund I LP 表示收购的 Atara Biotherapeutics 普通股 Belief 股票的实益所有权被低估","url":"https://stock-news.laohu8.com/highlight/detail?id=2437240336","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2437240336?lang=zh_cn&edition=full","pubTime":"2024-05-23 06:35","pubTimestamp":1716417314,"startTime":"0","endTime":"0","summary":"Adiumentum Capital Fund I LP 表示收购的 Atara Biotherapeutics 普通股 Belief 股票的实益所有权被低估","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230635179edac9fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230635179edac9fa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437195812","title":"Atara Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.15%报0.729美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437195812","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2437195812?lang=zh_cn&edition=full","pubTime":"2024-05-23 01:11","pubTimestamp":1716397875,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日01时11分,Atara Biotherapeutics, Inc.股票出现波动,股价急速拉升5.15%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Igm Biosciences, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃,换手率分别为332.69%、163.98%、48.24%,振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ,振幅分别为61.52%、57.14%、48.75%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。该信息摘要如下:HC Wainwright & Co.:重申Atara Biotherapeutics中性评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230111159680f16b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230111159680f16b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435985379","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435985379","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435985379?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:32","pubTimestamp":1715610756,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时32分,Atara Biotherapeutics, Inc.股票出现波动,股价快速下挫5.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.10%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、诺瓦瓦克斯医药涨幅较大,Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃,换手率分别为62.66%、37.16%、22.34%,振幅较大的相关个股有Tevogen Bio Holdings Inc.、Dbv Technologies、Portage Biotech Inc.,振幅分别为43.68%、36.84%、34.80%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223237861ecd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223237861ecd71&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434485497","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434485497","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434485497?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:32","pubTimestamp":1715347952,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时32分,Atara Biotherapeutics, Inc.股票出现异动,股价快速拉升5.59%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大,诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为32.69%、17.59%、6.65%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、诺瓦瓦克斯医药、内克塔治疗,振幅分别为31.88%、20.58%、12.50%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132328af137de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132328af137de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433789052","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433789052?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:54","pubTimestamp":1715093663,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时54分,Atara Biotherapeutics, Inc.股票出现异动,股价急速跳水5.21%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大,Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1395.34%、179.67%、170.06%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为41.69%、41.38%、38.52%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507225423861eb7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507225423861eb7eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433401017","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433401017","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433401017?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:13","pubTimestamp":1715012035,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时13分,Atara Biotherapeutics, Inc.股票出现波动,股价大幅跳水5.63%。截至发稿,该股报0.632美元/股,成交量47.3994万股,换手率0.39%,振幅9.57%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nrx Pharmaceuticals, Inc.、Tc Biopharm Plc涨幅较大,Tc Biopharm Plc、Allarity Therapeutics, Inc.、Nrx Pharmaceuticals, Inc.较为活跃,换手率分别为1167.44%、763.37%、71.88%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Tc Biopharm Plc、Nrx Pharmaceuticals, Inc.,振幅分别为95.51%、84.25%、68.10%。Atara Biotherapeutics, Inc.公司简介:Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700135579261097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700135579261097&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":-0.1011},{"period":"1month","weight":-0.1806},{"period":"3month","weight":-0.2722},{"period":"6month","weight":-0.1341},{"period":"1year","weight":-0.6261},{"period":"ytd","weight":0.0938}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。公司是一个临床阶段的生物制药公司,致力于开发对肌肉萎缩情况和肿瘤学严重的未满足的医疗需求的新疗法。公司的候选产品是针对肌肉生长抑制素和激活素生物制剂,是TGF-β蛋白超家族的成员,它在肌肉和其他许多身体组织的生长和维持中发挥作用。公司的主导候选产品,PINTA745,是在终末期肾病患者的第2阶段临床试验PEW。该公司第二候选产品为STM434,以及该公司预计将在2014年下半年进入STM434的第1阶段临床研究卵巢癌等实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.120552},{"month":2,"riseRate":0.3,"avgChangeRate":-0.046815},{"month":3,"riseRate":0.5,"avgChangeRate":0.062248},{"month":4,"riseRate":0.1,"avgChangeRate":-0.077789},{"month":5,"riseRate":0.4,"avgChangeRate":-0.075569},{"month":6,"riseRate":0.777778,"avgChangeRate":0.128062},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.068572},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.016397},{"month":9,"riseRate":0.666667,"avgChangeRate":0.009953},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.128758},{"month":11,"riseRate":0.8,"avgChangeRate":0.240727},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11122}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}